GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sol-Gel Technologies Ltd (STU:4SG) » Definitions » Other Assets for Insurance Companies

Sol-Gel Technologies (STU:4SG) Other Assets for Insurance Companies


View and export this data going back to 2019. Start your Free Trial

What is Sol-Gel Technologies Other Assets for Insurance Companies?

Other Assets for Insurance Companies only applies to insurance companies.


Sol-Gel Technologies Business Description

Industry
Traded in Other Exchanges
Address
7 Golda Meir Street, Weizmann Science Park, Ness Ziona, ISR, 7403650
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.